Distribution of HPV genotypes in women with cervical cancer in Auckland, New Zealand; A review of 50 specimens between 2000-2006

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 51, Issue 1, 2011, Pages 67-70

  Williamson, Deborah ^a   Nagappan, Radhika ^a   Sirikonda, Rao ^a   Rahnama, Fahimeh ^a   Thomas, Stephen ^a   Lovell Smith, Margaret ^a   Croxson, Margaret ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

cervical carcinoma; genotyping; human papillomavirus

Indexed keywords

DNA; VIRUS DNA;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; NEW ZEALAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE SECTION; TUMOR VIRUS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS GENE; VIRUS STRAIN; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; NEW ZEALAND; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 79951472499     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01251.x     Document Type: Article

References (18)

1. Parkin DM,. The global burden of infection associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
2. NZHIS Cancer Statistics.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV,. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265. (Pubitemid 34293391)
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19. (Pubitemid 29406813)
5. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. (Pubitemid 36159887)
6. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S,. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.
7. Cogliano V, Baan R, Straif K, et al. IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papillomaviruses. Lyon: International Agency for Research on Cancer, 2006.
8. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008; 9 (5): 425-434.
9. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM,. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989; 7: 209-214.
10. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ,. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-1062.
11. Greer CE, Peterson SL, Manos MM, et al. PCR Amplification from Paraffin-Embedded Tissues. Effects of Fixative and Fixation Time. AJCP 1991; 95: 117-124.
12. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT,. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989; 8 (12): 3905-3910. (Pubitemid 20016074)
13. Tawfik El-Mansi M, Cuschieri KS, Morris RG, Williams ARW,. Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients. Int J Gynecol Cancer 2006; 16: 1025-1031. (Pubitemid 43886721)
14. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121 (3): 621-632. (Pubitemid 46986496)
15. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
16. Brown DR, Kjaer SK, Sigurdson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. J Infect Dis 2009; 199: 926-935.
17. Wheeler CM, Kjaer SK, Sigurdson K, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV Types in sexually active women aged 16-26 years. J Infect Dis 2009; 199: 936-944.
18. Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301-314.